These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 30884015)

  • 1. Liver fibrosis markers as assessed by ultrasound elastography and serum samples: A large comparative study in hepatitis virus B and C liver diseases.
    Nishimura T; Iijima H; Nishikawa H; Kondo R; Yano H; Kage M; Aoki T; Nakano C; Yuri Y; Ishii N; Hasegawa K; Takata R; Yoh K; Sakai Y; Takashima T; Aizawa N; Ikeda N; Iwata Y; Enomoto H; Hirota S; Fujimoto J; Nishiguchi S
    Hepatol Res; 2019 Jul; 49(7):721-730. PubMed ID: 30884015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The validity of serum markers for fibrosis staging in chronic hepatitis B and C.
    Li J; Gordon SC; Rupp LB; Zhang T; Boscarino JA; Vijayadeva V; Schmidt MA; Lu M;
    J Viral Hepat; 2014 Dec; 21(12):930-7. PubMed ID: 24472062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of collagen proportionate areas in liver fibrosis quantification between chronic hepatitis B and C.
    Chen SH; Peng CY; Chiang IP; Lai HC; Lee CJ; Su WP; Kao JT; Chuang PH
    Medicine (Baltimore); 2016 Aug; 95(35):e4736. PubMed ID: 27583917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lymphocyte subpopulations, levels of interferon, and expression of their receptors in patients with chronic hepatitis B and C: Correlation with the species of viruses and the degree of liver fibrosis].
    Kalyuzhin OV; Ponezheva ZB; Semenova IV; Khokhlova ON; Serebrovskaya LV; Guseva TS; Parshina OV; Maleev VV
    Ter Arkh; 2017; 89(11):14-20. PubMed ID: 29260741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-based diagnostic tools for advanced fibrosis and cirrhosis in patients with chronic hepatitis B and C.
    Appourchaux K; Dokmak S; Resche-Rigon M; Treton X; Lapalus M; Gattolliat CH; Porchet E; Martinot-Peignoux M; Boyer N; Vidaud M; Bedossa P; Marcellin P; Bièche I; Estrabaud E; Asselah T
    Sci Rep; 2016 Oct; 6():34935. PubMed ID: 27731343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of virtual touch quantification for staging liver fibrosis in patients with hepatitis C, and factors affecting liver stiffness measurement failure compared with liver biopsy.
    Tsukano N; Miyase S; Saeki T; Mizobe K; Iwashita H; Arima N; Fujiyama S
    Hepatol Res; 2018 Apr; 48(5):373-382. PubMed ID: 29226524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic usefulness of real-time elastography for liver fibrosis in chronic viral hepatitis B and C.
    Kim YW; Kwon JH; Jang JW; Kim MJ; Oh BS; Chung KW; Park ES; Nam SW
    Gastroenterol Res Pract; 2014; 2014():210407. PubMed ID: 25180031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-invasive assessment of liver fibrosis in chronic viral hepatitis.
    Orasan OH; Iancu M; Sava M; Saplontai-Pop A; Cozma A; Sarlea ST; Lungoci C; Ungureanu MI; Negrean V; Sampelean D; Dumitrascu DL
    Eur J Clin Invest; 2015 Dec; 45(12):1243-51. PubMed ID: 26426402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in APRI and FIB-4 in HBeAg-negative treatment-naive chronic hepatitis B patients with significant liver histological lesions receiving 5-year entecavir therapy.
    Liu R; Guo J; Lu Y; Zhang L; Shen G; Wu S; Chang M; Hu L; Hao H; Li M; Xie Y
    Clin Exp Med; 2019 Aug; 19(3):309-320. PubMed ID: 31111345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of transient elastography for fibrosis assessment compared with large biopsies in chronic hepatitis B and C.
    Verveer C; Zondervan PE; ten Kate FJ; Hansen BE; Janssen HL; de Knegt RJ
    Liver Int; 2012 Apr; 32(4):622-8. PubMed ID: 22098684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy of transient elastography in assessing liver fibrosis in chronic viral hepatitis: A multicentre, retrospective study.
    Seo YS; Kim MY; Kim SU; Hyun BS; Jang JY; Lee JW; Lee JI; Suh SJ; Park SY; Park H; Jung EU; Kim BS; Kim IH; Lee TH; Um SH; Han KH; Kim SG; Paik SK; Choi JY; Jeong SW; Jin YJ; Lee KS; Yim HJ; Tak WY; Hwang SG; Lee YJ; Lee CH; Kim DG; Kang YW; Kim YS;
    Liver Int; 2015 Oct; 35(10):2246-55. PubMed ID: 25682719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transient elastography for measurement of liver stiffness measurement can detect early significant hepatic fibrosis in Japanese patients with viral and nonviral liver diseases.
    Obara N; Ueno Y; Fukushima K; Nakagome Y; Kakazu E; Kimura O; Wakui Y; Kido O; Ninomiya M; Kogure T; Inoue J; Kondo Y; Shiina M; Iwasaki T; Yamamoto T; Shimosegawa T
    J Gastroenterol; 2008; 43(9):720-8. PubMed ID: 18807134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing significant fibrosis using imaging-based elastography in chronic hepatitis B patients: Pilot study.
    Park HS; Choe WH; Han HS; Yu MH; Kim YJ; Jung SI; Kim JH; Kwon SY
    World J Gastroenterol; 2019 Jul; 25(25):3256-3267. PubMed ID: 31333316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative assessment of liver fibrosis by computerized morphometry in naïve patients with chronic hepatitis B and C.
    Sturm N; Marlu A; Arvers P; Zarski JP; Leroy V
    Liver Int; 2013 Mar; 33(3):428-38. PubMed ID: 23402612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of gamma-glutamyltranspeptidase-to-platelet ratio in diagnosis of hepatic fibrosis in patients with chronic hepatitis B.
    Hu YC; Liu H; Liu XY; Ma LN; Guan YH; Luo X; Ding XC
    World J Gastroenterol; 2017 Nov; 23(41):7425-7432. PubMed ID: 29151696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stepwise application of fibrosis index based on four factors, red cell distribution width-platelet ratio, and aspartate aminotransferase-platelet ratio for compensated hepatitis B fibrosis detection.
    Chen YP; Hu XM; Liang XE; Huang LW; Zhu YF; Hou JL
    J Gastroenterol Hepatol; 2018 Jan; 33(1):256-263. PubMed ID: 28452125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective evaluation of serum markers APRI and AST/ALT for assessing liver fibrosis and cirrhosis in chronic hepatitis B and C patients with hepatocellular carcinoma.
    Lin CS; Chang CS; Yang SS; Yeh HZ; Lin CW
    Intern Med; 2008; 47(7):569-75. PubMed ID: 18379139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acoustic radiation force impulse elastography and serum fibrosis markers in chronic hepatitis C.
    Silva Junior RG; Schmillevitch J; Nascimento Mde F; Miranda ML; Brant PE; Schulz PO; Vieira A; Szutan LA
    Scand J Gastroenterol; 2014 Aug; 49(8):986-92. PubMed ID: 24742130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrosis index based on four factors better predicts advanced fibrosis or cirrhosis than aspartate aminotransferase/platelet ratio index in chronic hepatitis C patients.
    Wang CC; Liu CH; Lin CL; Wang PC; Tseng TC; Lin HH; Kao JH
    J Formos Med Assoc; 2015 Oct; 114(10):923-8. PubMed ID: 26279173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of biglycan and osteopontin as non-invasive markers of liver fibrosis in patients with chronic hepatitis B virus and chronic hepatitis C virus.
    Sobhy A; Fakhry M M; A Azeem H; Ashmawy AM; Omar Khalifa H
    J Investig Med; 2019 Mar; 67(3):681-685. PubMed ID: 30385593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.